Evidence Dossiers
Structured evidence packages adapted for your local market — comparators, guidelines, and clinical data reframed for affiliate medical and access teams.
What you get
Country evidence brief
Market-specific evidence summary with local comparator context
Comparator landscape
Mapping of local treatment options and competitive positioning
Clinical data package
Key trial data formatted for local medical and access needs
Local market fit
Every dossier is adapted to local comparators, treatment guidelines, and payer requirements — not just translated from global.
Structured evidence logic
Clinical data, health economics arguments, and competitive context organized in a reusable format for multiple stakeholders.
Affiliate-ready delivery
Outputs designed for MSLs, medical directors, and access teams — ready to use without additional adaptation.
About this service
Evidence packages built for local realities
Global evidence packages rarely work at the affiliate level without adaptation. Local comparators differ, treatment sequences change, and payer requirements vary — a global dossier that ignores these realities loses credibility in front of local decision-makers.
We build structured evidence dossiers from scratch or adapt existing global materials for specific markets. Every package maps local comparators, integrates country-specific clinical guidelines, and frames the evidence in a way that resonates with local HTA requirements and payer logic.
The result is a set of evidence documents your affiliate teams can actually use — for MSL conversations, payer meetings, and internal strategic alignment.
Deliverables
What you get
Country evidence brief
Market-specific evidence summary with local comparator context
Comparator landscape
Mapping of local treatment options and competitive positioning
Clinical data package
Key trial data formatted for local medical and access needs
Field-ready slides
Presentation materials for MSL and medical director use
HTA evidence summary
Structured evidence for local health technology assessment
Reimbursement support pack
Documentation for local access and reimbursement teams
How we work
Five phases to market-ready evidence
01
Map local landscape
Identify local comparators, treatment guidelines, and payer requirements for the target market.
02
Audit global evidence
Review existing data packages and identify gaps for local adaptation.
03
Build local narrative
Reframe clinical evidence around local comparators and treatment sequences.
04
Draft deliverables
Create field-ready documents, slides, and summary materials.
05
Review & deliver
Quality check with local context experts before handoff to affiliate teams.
AI-enabled workflow
AI-accelerated evidence mapping, expert-adapted output
AI accelerates literature search, comparator mapping, and data extraction. Medical experts adapt the narrative for local clinical and payer context.
What AI does
- Automated literature search across PubMed and clinical databases
- Comparator landscape extraction from treatment guidelines
- Data table generation and cross-reference checking
- Draft evidence summary generation for expert review
What MAG experts do
- Local market clinical expertise and guideline interpretation
- Payer logic adaptation and HTA requirement mapping
- Narrative framing for local decision-makers
- Final quality review and scientific accuracy validation
Evidence Scanner™ modules used
PubMed/Web Monitoring
Fact-Checker
Literature Triage
Proof
How this service works in practice
Country-level evidence adaptation for 8 CEE pharma affiliates — one core brief, 8 locally adapted versions
Result:All 8 markets launched within the same quarter
Oncology
Read case →
Global value dossier localized for 5 MENA markets: SGLT2 inhibitor in heart failure
Result:Positive reimbursement in 3/5 markets within 12 months
Cardiology
Read case →
Biosimilar switching evidence dossier: immunogenicity and efficacy data for 6 EU markets
Result:Used in tender submissions across all 6 markets
Immunology
Read case →
Solves these challenges
Related problems
HQ sent a global deck — affiliate needs a local brief by Thursday
200 slides of global data need to become a 12-slide country brief with local comparators and guidelines.
See how we solve it →
Global dossier uses wrong comparator for local HTA
The global value argument doesn’t hold when the local payer evaluates against a different comparator.
See how we solve it →
RWE data exists but was never turned into a usable HTA dossier
The data has been collected, but no one built the payer-facing argument from it.
See how we solve it →
Frequently asked
Common questions
How is this different from translation?
Translation converts language. Evidence adaptation converts logic — local comparators, local treatment sequences, local payer requirements. We rebuild the argument for each market, not just the words.
How many markets can you cover simultaneously?
We regularly handle 5–10 markets in parallel. Each dossier is built by a team that understands the local clinical and access landscape.
Can you work with our existing global dossier?
Yes. We can adapt an existing global evidence package or build a new one from scratch based on your clinical data and strategic needs.
What therapeutic areas do you cover?
We work across oncology, cardiology, rare diseases, immunology, endocrinology, and infectious diseases — with deep expertise in complex evidence landscapes.
How do you ensure scientific accuracy?
Every deliverable goes through medical expert review. We cross-check claims against source publications and ensure all data is traceable and MLR-ready.
Need evidence adapted for your market?
Book a 20-minute scoping call. We’ll review your evidence needs and suggest the right approach.
Book a scoping call →
Browse all services
Need evidence that works locally?
Tell us your market and therapeutic area. We’ll build evidence packages your affiliate teams can actually use.
AI infrastructure
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Electronic data capture with AI-assisted quality checks
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
// Evidence dossier — comparator mapping
search("comparator_landscape.json", {
mode: "local_comparator_map",
markets: 8,
output: "evidence_brief + comparator_matrix",
})
Mapping comparators across 8 markets...
Comparator Map
8 market profiles generated. 3 markets use different first-line comparator. Sequencing logic diverges in 5/8 markets. Evidence gaps flagged for 2 priority markets...